BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Replikins Release: Recent Outbreak of Hand-Foot-Mouth Disease in 2.2 Million Children (WHO) Preceded and Predicted by Increase in the HFMD Genomic Replikin® Count


2/20/2013 9:51:24 AM

LONDON, Feb. 19, 2013 /PRNewswire/ -- Bioradar UK Ltd has found that the virus genomic Replikin® Count in Hand-Foot-Mouth Disease (HFMD) increased fourfold worldwide from 2005 to 2012 (Figure). All HFMD genomes on Pubmed were analyzed for Replikins (References). Increase in the genomic Replikin®Count (number of genomic Replikins per 100 amino acids) alone preceded and predicted the increases in the number of cases (p<0.001).

(Photo: http://photos.prnewswire.com/prnh/20130219/PH62841 )

From 2010 to 2011, Counts exceeding 4.0 appeared and have since continued to increase in percent of the total virus population. There were 30,000 cases in China in 2008 and 2.2 million in 2012 (WHO). Genomic Replikin®Counts, alone, have now been correct 12 successive times in different virus species and strains at predicting outbreaks (References). Replikin®Count prediction has permitted the design of solid phase completely synthetic Replikins HFMD Vaccine.

Contact: sbogoch@replikins.com, Tel 646-320-5910

References:

  1. Nature Precedings (8 Bogoch publications): http://precedings.nature.com/users/549471c7b195af1864d2f1b1996f6064
  2. website http://www.replikins.com

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.

SOURCE Replikins



Read at BioSpace.com

Replikins
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES